Carfilzomib activates ER stress and JNK/p38 MAPK signaling to promote apoptosis in hepatocellular carcinoma cells
Open Access
- 1 March 2024
- journal article
- research article
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 56 (5) , 697-708
Abstract
Hepatocellular carcinoma (HCC) is one of the most prevalent and deadly cancers in the world, which is frequently diagnosed at a late stage. HCC patients have a poor prognosis due to the lack of an efficacious therapeutic strategy. Approved drug repurposing is a way for accelerating drug discovery and can significantly reduce the cost of drug development. Carfilzomib (CFZ) is a second-generation proteasome inhibitor, which is highly efficacious against multiple myeloma and has been reported to possess potential antitumor activities against multiple cancers. However, the underlying mechanism of CFZ on HCC is still unclear. Here, we show that CFZ inhibits the proliferation of HCC cells through cell cycle arrest at the G2/M phase and suppresses the migration and invasion of HCC cells by inhibiting epithelial-mesenchymal transition. We also find that CFZ promotes reactive oxygen species production to induce endoplasmic reticulum (ER) stress and activate JNK/p38 MAPK signaling in HCC cells, thus inducing cell death in HCC cells. Moreover, CFZ significantly inhibits HCC cell growth in a xenograft mouse model. Collectively, our study elucidates that CFZ impairs mitochondrial function and activates ER stress and JNK/p38 MAPK signaling, thus inhibiting HCC cell and tumor growth. This indicates that CFZ has the potential as a therapeutic drug for HCC.Keywords
This publication has 52 references indexed in Scilit:
- The mechanism and consequences of BRAF inhibitor resistance in melanomaGenome Instability & Disease, 2023
- Mitochondrial DNA mutation affects the pluripotency of embryonic stem cells with metabolism modulationGenome Instability & Disease, 2022
- Endoplasmic reticulum stress in liver diseasesHepatology, 2022
- Mitochondrial DNA copy number in human disease: the more the better?FEBS Letters, 2020
- Artemisinin suppresses hepatocellular carcinoma cell growth, migration and invasion by targeting cellular bioenergetics and Hippo-YAP signalingArchives of Toxicology, 2019
- Mitochondrial DNA damage and reactive oxygen species in neurodegenerative diseaseFEBS Letters, 2017
- Driving Cancer Tumorigenesis and Metastasis Through UPR Signaling2017
- Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancerActa Histochemica, 2016
- Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myelomaInternational Journal of Hematology, 2016
- A Possible Antineoplastic Potential of Selective, Irreversible Proteasome Inhibitor, Carfilzomib on Chemically Induced Hepatocarcinogenesis in RatsJournal of Biochemical and Molecular Toxicology, 2014